KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Amgen (AMGN) Other Gross PP&E Adjustments (2016 - 2026)

Amgen has reported Other Gross PP&E Adjustments over the past 18 years, most recently at -$2.7 billion for Q1 2026.

  • For Q1 2026, Other Gross PP&E Adjustments rose 12.9% year-over-year to -$2.7 billion; the TTM value through Mar 2026 reached -$8.7 billion, up 15.53%, while the annual FY2025 figure was $18.9 billion, 12.46% up from the prior year.
  • Other Gross PP&E Adjustments for Q1 2026 was -$2.7 billion at Amgen, down from $18.9 billion in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $18.9 billion in Q4 2025 and troughed at -$3.6 billion in Q1 2024.
  • A 5-year average of $2.2 billion and a median of -$1.3 billion in 2022 define the central range for Other Gross PP&E Adjustments.
  • Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 69.6% in 2023 and later crashed 71.43% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at $9.2 billion in 2022, then skyrocketed by 69.6% to $15.6 billion in 2023, then increased by 7.77% to $16.8 billion in 2024, then rose by 12.46% to $18.9 billion in 2025, then plummeted by 114.29% to -$2.7 billion in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for AMGN at -$2.7 billion in Q1 2026, $18.9 billion in Q4 2025, and -$900.0 million in Q3 2025.